Sonata Therapeutics

Sonata Therapeutics

Edit info

  • Founded: 2022
  • Location: Watertown, MA
  • Employee range: 0 - 0
  • Clinical stage: RD
  • Therapy area: Oncology
  • Drug types: ONC, GEN
  • Lead product: SNT-3010912
  • Funding: not disclosed
  • Investors: Flagship Pioneering


sonatatx.com

linkedin.com

job board


Drug notes:

SNT-20109 RD oncology; SNT-101 RD oncology; SNT-3012 RD pancreatic & colorectal cancers

About:

Sonata Therapeutics is developing drugs to reprogram the cellular microenvironment to treat disease. The cellular microenvironment - consisting of signaling molecules such as inflammatory and growth factors - plays an important role in human biology and disease. However, the network of inputs, constituents and targets of the microenvironment have not been fully understood. Sonata is performing a systematic, comprehensive characterization of the cellular microenvironment using pharmacologic and genetic perturbations in diseases of high unmet clinical need. This information feeds into their product-platform to identify new targets for therapeutics. Sonata is generating both small molecule drugs and genetic therapeutics that trigger a diversity of signals to re-engineer the cellular microenvironment.

Jobs:

Post a job


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com